Skip to main content
. Author manuscript; available in PMC: 2020 Nov 10.
Published in final edited form as: Bone Marrow Transplant. 2020 May 10;55(11):2160–2169. doi: 10.1038/s41409-020-0926-1

Figure 3.

Figure 3.

Overall survival of patients who went to allo-HSCT less than 80 days from CAR T cell therapy compared to patients who went to allo-HSCT >80 days from CAR T cell therapy.